Oncology

Latest News

CureCancer | Image Credit: © MMPhoto21-sotck.adobe.com
COA 2025: Insight, Innovation, and Independent Strength

May 5th 2025

The 2025 Community Oncology Conference empowered attendees with insights on advocacy, innovation, and practical strategies for enhancing community cancer care.

COA logo | Image Credit: © Amy Kinnamon
Community Oncology Reacts to Trump's Drug Pricing Executive Order

May 2nd 2025

Melanoma & Skin Cancer Awareness Month | Image credit: Waseem Ali Khan - stock.adobe.com
5 Things You Should Know About Skin Cancer

May 2nd 2025

stethoscopewithcompass | Image Credit: © Talaj-stock.adobe.com
Patient Navigation Is Nonnegotiable in Cancer Care

May 1st 2025

Liver cancer - Sebastian Kaulitzki - stock.adobe.com.jpg
Elevated HLA-G Seen in HCC Driven by Viral Infections, Fatty Liver

May 1st 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Episode 10 - Comparative Effectiveness Research
October 8th 2014

Episode 10 - Comparative Effectiveness Research

Episode 9 - Analyzing Incentive Programs
October 8th 2014

Episode 9 - Analyzing Incentive Programs

Episode 8 - Immunotherapy and Pathways: Safety Considerations
October 8th 2014

Episode 8 - Immunotherapy and Pathways: Safety Considerations

Episode 7 - Inclusion of Generic Drugs in Pathways
October 8th 2014

Episode 7 - Inclusion of Generic Drugs in Pathways

Episode 6 - Measuring the Success of Clinical Pathways
October 8th 2014

Episode 6 - Measuring the Success of Clinical Pathways

Episode 5 - Utilization of Clinical Pathways in Oncology
October 8th 2014

Episode 5 - Utilization of Clinical Pathways in Oncology

Episode 4 - Potential Impact of Data Integration Projects
October 8th 2014

Episode 4 - Potential Impact of Data Integration Projects

Episode 3 - Examining Data Integration Platforms
October 8th 2014

Episode 3 - Examining Data Integration Platforms

Episode 2 - Gaps in Data Exchange From a Payer Perspective
October 8th 2014

Episode 2 - Gaps in Data Exchange From a Payer Perspective

Episode 1 - Evidence-Based Decisions for Data Generation, Collection, and Analysis
October 8th 2014

Episode 1 - Evidence-Based Decisions for Data Generation, Collection, and Analysis

Site Logo
October 8th 2014

Collaboration Will Help Match the Right Patient With the Right Trial

The collaboration between med fusion and GenomOncology promises improved outcomes in personalized cancer trials.
Site Logo
October 7th 2014

In The Literature: TNF-α Antagonists in RA Patients Reduces Cancer Risk

A Taiwan study found a significantly reduced risk of cancer among RA patients on biologics.
Site Logo
October 7th 2014

Cancer and Mental Health

Results of a large study performed across cancer centers in Germany, published online October 6, 2014 in the Journal of Clinical Oncology, show that 32% of people with cancer experienced some form of clinically relevant mental health challenge, such as anxiety, depressive and adjustment disorders.
Site Logo
October 6th 2014

Dr Peter B. Bach Outlines Framework for Tying Price of Cancer Drugs to Indication, Value

Mary K. Caffrey
Peter B. Bach, MD, MAPP, Memorial Sloan Kettering Cancer Center, writes in the Journal of the American Medical Association that cancer drugs could be charged different prices by indication, since the value for patients varies. His article appeared days before an appearance on 60 Minutes to discuss the high price of cancer drugs.
Site Logo
October 6th 2014

BMS to Collaborate with Novartis to Test Nivolumab in NSCLC

Combining nivolumab, an immuno-oncology molecule, with 1 of 3 targeted agents from Novartis is expected to improve patient response in NSCLC.
Site Logo
October 6th 2014

Study Identifies Lapses in Safe Chemotherapy Administration

Chemotherapy drugs, which could be poisons, can result in adverse health outcomes in healthcare workers who administer them to patients without adequate safety measures.
Site Logo
October 6th 2014

Vosaroxin Fails in Phase 3 AML Trials in the Elderly

Sunesis Pharmaceuticals announced the failure of a phase 3 study Monday morning. The company's experimental drug vosaroxin did not extend survival of elderly patients with advanced acute myeloid leukemia compared to a placebo.
Site Logo
October 5th 2014

Avoid Unnecessary Pap Tests: Study Concludes

A study published in the American Journal of Preventive Medicine found that lack of awareness resulted in women over 65 and those who had undergone hysterectomy routinely undergoing a Pap test.
Site Logo
October 5th 2014

ASCO Provides Input on CMMI's

ASCO has been working in parallel with various other institutions to generate a patient-centered oncology payment reform model.
Site Logo
October 5th 2014

In The Literature: NSAID/Statin Influence on PSA in High-Risk Prostate Cancer Patients

The study, published in Cancer Epidemiology, Biomarkers & Prevention, evaluated the influence of NSAIDs and statins on PSA levels in men with a high prostate cancer risk.
Site Logo
October 5th 2014

Ariad's Investigational NSCLC Drug: Breakthrough by FDA

The molecule is being evaluated in crizotinib-resistant ALK-positive NSCLC patients. The results from the phase 1/2 trial with AP26113 were presented at the 2014 European Cancer Congress.
Site Logo
October 4th 2014

JCO Study: MMA Did Not Influence Fee-For-Service Prescribing

The study by Kaiser Permanente found that prescription practices were not much influenced by the decrease in fee-for-service payments for outpatient chemotherapy, due the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
Site Logo
October 4th 2014

Cigna Refers to NCCN Guidelines for Oncology Coverage Decisions

The Cigna-NCCN collaboration will benefit about 12.5 million members.
Site Logo
October 4th 2014

Merck's HPV Vaccine Effective Against 9 Subtypes

The study, conducted in Austria, evaluated the potency of the 9-valent vaccine in preventing the development of cervical precancer in women infected with HPV.
Site Logo
October 3rd 2014

Ambiguous Mammograms: An Emotional and Financial Burden

A study published in a supplement to the Journal of Women's Health looks to the widespread impact of newer screening technologies to improve outcomes.
Site Logo
October 3rd 2014

Value Discussion Reemerges at NICE: Roche's Gazyvaro Rejected

Following Kadcyla, NICE has now rejected another drug from Roche: Gazyvaro for CLL, citing ambiguities in the company's filing and the high cost.
Site Logo
October 3rd 2014

Literature: Germline BRCA Mutations Increase Susceptibility to Salivary Gland Cancer

The study, published online in JAMA Otolaryngology - Head & Neck Surgery, found a significant increase in the rate of head and neck cancers in individuals carrying a BRCA mutation.
Site Logo
October 2nd 2014

New Receptor Target for Glioblastoma Multiforme Holds Promise

A review published in Neuro-Oncology provides insight into some of the molecules being developed to target IL13Rα2 in brain tumors.
Site Logo
October 1st 2014

ASCO: Obesity a Risk Factor and Complication in Cancer

ASCO has called for raising awareness to control obesity, as it is not just a risk factor for developing diabetes but also for cancer.
Site Logo
September 30th 2014

ESMO 2014: New Regimen for BRAF-mutated Melanoma

Results from 2 phase 3 trials showed better response rates, progression-free survival, and overall survival when a BRAF inhibitor was combined with a MEK inhibitor, compared with a BRAF inhibitor alone.
<1
...
149150151152153154155156157
...
184>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo